Pulse Biosciences, Inc. (PLSE) stock forecast and price target
Price $50.44 · data as of November 13, 2026
12-month price target
Average target$67.67
Upside / downside+34.2%
Analysts6
ConsensusStrong buy
Low $60.00Average $67.67High $74.00
Gold marker: average target · white marker: today’s price ($50.44)
Analyst ratings
Strong buy 1Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.05 | −38.7% | $2M |
| Next fiscal year ends December 31, 2027 | $-1.16 | −10.6% | $5M |
| Next quarter ends December 31, 2026 | $-0.28 | −53.7% | $560000 |
| Quarter after ends March 31, 2027 | $-0.29 | −20.1% | $743330 |
Consensus of the analysts covering Pulse Biosciences, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Pulse Biosciences stock price target?
The average 12-month target from 6 analysts is $67.67, 34.2% above the current price of $50.44 Targets range from $60.00 to $74.00.
Is Pulse Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Pulse Biosciences expected to earn?
Analysts expect EPS of $-1.05 for the fiscal year ending December 31, 2026 and $-1.16 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.